APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Budesonide Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Budesonide Capsules Market Outlook and Growth Opportunities 2026

Report ID 173973030420 December 2025190 pages

Choose your research edition.

Industry ResearchBudesonide Capsules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Budesonide Capsules Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Budesonide Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Budesonide Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Budesonide Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Budesonide Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Budesonide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Budesonide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Budesonide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Budesonide Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Budesonide Capsules market include Amneal, Mayne Pharma, Perrigo, Sciecure Pharma, Tillotts Pharma, Zydus Pharmaceuticals, Mylan and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Budesonide Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Budesonide Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Budesonide Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Budesonide Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Budesonide Capsules Segment by Company

Amneal

Mayne Pharma

Perrigo

Sciecure Pharma

Tillotts Pharma

Zydus Pharmaceuticals

Mylan

Teva

Budesonide Capsules Segment by Type

1mg

2mg

3mg

Budesonide Capsules Segment by Application

Autoimmune Hepatitis

Crohn's Disease

Collagenous Colitis

Budesonide Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Budesonide Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Budesonide Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Budesonide Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Budesonide Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Budesonide Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Budesonide Capsules industry.

Chapter 3: Detailed analysis of Budesonide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Budesonide Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Budesonide Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Budesonide Capsules Industry Trends Table 2. Budesonide Capsules Industry Drivers Table 3. Budesonide Capsules Industry Opportunities and Challenges Table 4. Budesonide Capsules Industry Restraints Table 5. Global Budesonide Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Budesonide Capsules Revenue Share by Company (2021-2026) Table 7. Global Budesonide Capsules Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Budesonide Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Budesonide Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Budesonide Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Budesonide Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Budesonide Capsules Company, Product Type & Application Table 13. Global Budesonide Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Budesonide Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1mg Table 18. Significant Companies of 2mg Table 19. Significant Companies of 3mg Table 20. Global Budesonide Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Budesonide Capsules Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Budesonide Capsules Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Budesonide Capsules Sales Volume Share by Type (2021-2026) Table 24. Global Budesonide Capsules Sales Volume Share by Type (2027-2032) Table 25. Global Budesonide Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Budesonide Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Budesonide Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Budesonide Capsules Sales Value Share by Type (2021-2026) Table 29. Global Budesonide Capsules Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Autoimmune Hepatitis Table 31. Significant Companies of Crohn's Disease Table 32. Significant Companies of Collagenous Colitis Table 33. Global Budesonide Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Budesonide Capsules Sales Volume by Application (2021-2026) & (W Units) Table 35. Global Budesonide Capsules Sales Volume by Application (2027-2032) & (W Units) Table 36. Global Budesonide Capsules Sales Volume Share by Application (2021-2026) Table 37. Global Budesonide Capsules Sales Volume Share by Application (2027-2032) Table 38. Global Budesonide Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Budesonide Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Budesonide Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Budesonide Capsules Sales Value Share by Application (2021-2026) Table 42. Global Budesonide Capsules Sales Value Share by Application (2027-2032) Table 43. Global Budesonide Capsules Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Budesonide Capsules Sales by Region (2021-2026) & (W Units) Table 45. Global Budesonide Capsules Sales Market Share by Region (2021-2026) Table 46. Global Budesonide Capsules Sales by Region (2027-2032) & (W Units) Table 47. Global Budesonide Capsules Sales Market Share by Region (2027-2032) Table 48. Global Budesonide Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Budesonide Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Budesonide Capsules Sales Value Share by Region (2021-2026) Table 51. Global Budesonide Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Budesonide Capsules Sales Value Share by Region (2027-2032) Table 53. Global Budesonide Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Budesonide Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Budesonide Capsules Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Global Budesonide Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 58. Global Budesonide Capsules Sales Market Share by Country (2021-2026) Table 59. Global Budesonide Capsules Sales by Country (2027-2032) & (W Units) Table 60. Global Budesonide Capsules Sales Market Share by Country (2027-2032) Table 61. Global Budesonide Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Budesonide Capsules Sales Value Market Share by Country (2021-2026) Table 63. Global Budesonide Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Budesonide Capsules Sales Value Market Share by Country (2027-2032) Table 65. Amneal Company Information Table 66. Amneal Business Overview Table 67. Amneal Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Amneal Budesonide Capsules Product Portfolio Table 69. Amneal Recent Development Table 70. Mayne Pharma Company Information Table 71. Mayne Pharma Business Overview Table 72. Mayne Pharma Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Mayne Pharma Budesonide Capsules Product Portfolio Table 74. Mayne Pharma Recent Development Table 75. Perrigo Company Information Table 76. Perrigo Business Overview Table 77. Perrigo Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Perrigo Budesonide Capsules Product Portfolio Table 79. Perrigo Recent Development Table 80. Sciecure Pharma Company Information Table 81. Sciecure Pharma Business Overview Table 82. Sciecure Pharma Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sciecure Pharma Budesonide Capsules Product Portfolio Table 84. Sciecure Pharma Recent Development Table 85. Tillotts Pharma Company Information Table 86. Tillotts Pharma Business Overview Table 87. Tillotts Pharma Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Tillotts Pharma Budesonide Capsules Product Portfolio Table 89. Tillotts Pharma Recent Development Table 90. Zydus Pharmaceuticals Company Information Table 91. Zydus Pharmaceuticals Business Overview Table 92. Zydus Pharmaceuticals Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Zydus Pharmaceuticals Budesonide Capsules Product Portfolio Table 94. Zydus Pharmaceuticals Recent Development Table 95. Mylan Company Information Table 96. Mylan Business Overview Table 97. Mylan Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Mylan Budesonide Capsules Product Portfolio Table 99. Mylan Recent Development Table 100. Teva Company Information Table 101. Teva Business Overview Table 102. Teva Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Teva Budesonide Capsules Product Portfolio Table 104. Teva Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Budesonide Capsules Distributors List Table 108. Budesonide Capsules Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Budesonide Capsules Product Image Figure 2. Global Budesonide Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Budesonide Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Budesonide Capsules Sales (2021-2032) & (W Units) Figure 5. Global Budesonide Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Budesonide Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1mg Image Figure 10. 2mg Image Figure 11. 3mg Image Figure 12. Global Budesonide Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Budesonide Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Budesonide Capsules Sales Volume Share by Type (2021-2032) Figure 15. Global Budesonide Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Budesonide Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Budesonide Capsules Sales Value Share by Type (2021-2032) Figure 18. Autoimmune Hepatitis Image Figure 19. Crohn's Disease Image Figure 20. Collagenous Colitis Image Figure 21. Global Budesonide Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Budesonide Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Budesonide Capsules Sales Volume Share by Application (2021-2032) Figure 24. Global Budesonide Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Budesonide Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Budesonide Capsules Sales Value Share by Application (2021-2032) Figure 27. Global Budesonide Capsules Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 28. Global Budesonide Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Budesonide Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Budesonide Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Budesonide Capsules Sales Value (2021-2032) & (US$ Million) Figure 32. North America Budesonide Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Budesonide Capsules Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Budesonide Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Budesonide Capsules Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Budesonide Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Budesonide Capsules Sales Value (2021-2032) & (US$ Million) Figure 38. South America Budesonide Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Budesonide Capsules Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Budesonide Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Budesonide Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Budesonide Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Budesonide Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Budesonide Capsules Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Budesonide Capsules Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 2mg
  • 3mg
Applications
  • Autoimmune Hepatitis
  • Crohn's Disease
  • Collagenous Colitis
Companies covered
  • Amneal
  • Mayne Pharma
  • Perrigo
  • Sciecure Pharma
  • Tillotts Pharma
  • Zydus Pharmaceuticals
  • Mylan
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Budesonide Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Budesonide Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Budesonide Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Budesonide Capsules Market Dynamics
  1. 2.1 Budesonide Capsules Industry Trends
  2. 2.2 Budesonide Capsules Industry Drivers
  3. 2.3 Budesonide Capsules Industry Opportunities and Challenges
  4. 2.4 Budesonide Capsules Industry Restraints
3 Budesonide Capsules Market by Company
  1. 3.1 Global Budesonide Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Budesonide Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Budesonide Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Budesonide Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Budesonide Capsules Company Ranking (2024-2026)
  6. 3.6 Global Budesonide Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Budesonide Capsules Company Product Type and Application
  8. 3.8 Global Budesonide Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Budesonide Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Budesonide Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Budesonide Capsules Market by Type
  1. 4.1 Budesonide Capsules Type Introduction
  2. 4.1.1 1mg
  3. 4.1.2 2mg
  4. 4.1.3 3mg
  5. 4.2 Global Budesonide Capsules Sales Volume by Type
  6. 4.2.1 Global Budesonide Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Budesonide Capsules Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Budesonide Capsules Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Budesonide Capsules Sales Value by Type
  10. 4.3.1 Global Budesonide Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Budesonide Capsules Sales Value by Type (2021-2032)
  12. 4.3.3 Global Budesonide Capsules Sales Value Share by Type (2021-2032)
5 Budesonide Capsules Market by Application
  1. 5.1 Budesonide Capsules Application Introduction
  2. 5.1.1 Autoimmune Hepatitis
  3. 5.1.2 Crohn's Disease
  4. 5.1.3 Collagenous Colitis
  5. 5.2 Global Budesonide Capsules Sales Volume by Application
  6. 5.2.1 Global Budesonide Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Budesonide Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Budesonide Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Budesonide Capsules Sales Value by Application
  10. 5.3.1 Global Budesonide Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Budesonide Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Budesonide Capsules Sales Value Share by Application (2021-2032)
6 Budesonide Capsules Regional Sales and Value Analysis
  1. 6.1 Global Budesonide Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Budesonide Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Budesonide Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Budesonide Capsules Sales by Region (2027-2032)
  5. 6.3 Global Budesonide Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Budesonide Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Budesonide Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Budesonide Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Budesonide Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Budesonide Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Budesonide Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Budesonide Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Budesonide Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Budesonide Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Budesonide Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Budesonide Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Budesonide Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Budesonide Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Budesonide Capsules Sales Value Share by Country, 2025 VS 2032
7 Budesonide Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Budesonide Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Budesonide Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Budesonide Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Budesonide Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Budesonide Capsules Sales by Country (2027-2032)
  6. 7.4 Global Budesonide Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Budesonide Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Budesonide Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Budesonide Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Budesonide Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Budesonide Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Budesonide Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Budesonide Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Budesonide Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Budesonide Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Budesonide Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Budesonide Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Budesonide Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Budesonide Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Budesonide Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Budesonide Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Budesonide Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Budesonide Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Budesonide Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Budesonide Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Budesonide Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Budesonide Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Budesonide Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Budesonide Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Budesonide Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Budesonide Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Budesonide Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Budesonide Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Budesonide Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Budesonide Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Budesonide Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Budesonide Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Budesonide Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amneal
  2. 8.1.1 Amneal Company Information
  3. 8.1.2 Amneal Business Overview
  4. 8.1.3 Amneal Budesonide Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amneal Budesonide Capsules Product Portfolio
  6. 8.1.5 Amneal Recent Developments
  7. 8.2 Mayne Pharma
  8. 8.2.1 Mayne Pharma Company Information
  9. 8.2.2 Mayne Pharma Business Overview
  10. 8.2.3 Mayne Pharma Budesonide Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mayne Pharma Budesonide Capsules Product Portfolio
  12. 8.2.5 Mayne Pharma Recent Developments
  13. 8.3 Perrigo
  14. 8.3.1 Perrigo Company Information
  15. 8.3.2 Perrigo Business Overview
  16. 8.3.3 Perrigo Budesonide Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Perrigo Budesonide Capsules Product Portfolio
  18. 8.3.5 Perrigo Recent Developments
  19. 8.4 Sciecure Pharma
  20. 8.4.1 Sciecure Pharma Company Information
  21. 8.4.2 Sciecure Pharma Business Overview
  22. 8.4.3 Sciecure Pharma Budesonide Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sciecure Pharma Budesonide Capsules Product Portfolio
  24. 8.4.5 Sciecure Pharma Recent Developments
  25. 8.5 Tillotts Pharma
  26. 8.5.1 Tillotts Pharma Company Information
  27. 8.5.2 Tillotts Pharma Business Overview
  28. 8.5.3 Tillotts Pharma Budesonide Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Tillotts Pharma Budesonide Capsules Product Portfolio
  30. 8.5.5 Tillotts Pharma Recent Developments
  31. 8.6 Zydus Pharmaceuticals
  32. 8.6.1 Zydus Pharmaceuticals Company Information
  33. 8.6.2 Zydus Pharmaceuticals Business Overview
  34. 8.6.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Pharmaceuticals Budesonide Capsules Product Portfolio
  36. 8.6.5 Zydus Pharmaceuticals Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Budesonide Capsules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Budesonide Capsules Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Teva
  44. 8.8.1 Teva Company Information
  45. 8.8.2 Teva Business Overview
  46. 8.8.3 Teva Budesonide Capsules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Teva Budesonide Capsules Product Portfolio
  48. 8.8.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Budesonide Capsules Value Chain Analysis
  2. 9.1.1 Budesonide Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Budesonide Capsules Sales Mode & Process
  6. 9.2 Budesonide Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Budesonide Capsules Distributors
  9. 9.2.3 Budesonide Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst